Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: Relationship to histologic assessment of hypoxia and fibrosis

Radiology

Volumn 254, Issue 1, 2010, Pages 110-118

  McPhail, Lesley D ^a,c   Robinson, Simon P ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; CARCINOGEN; METHYLNITROSOUREA; PIMONIDAZOLE; CARBON DIOXIDE; CYTOKERATIN 14; NITROIMIDAZOLE DERIVATIVE; OXYGEN; RADIOSENSITIZING AGENT; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CHEMICAL CARCINOGENESIS; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; HISTOLOGY; HYPOXIA; LINEAR REGRESSION ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; SPECTROMETER; ANIMAL; ANOXIA; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FIBROSIS; METABOLISM; METHODOLOGY; NECROSIS; PATHOLOGY; STATISTICAL MODEL; WISTAR RAT;

ANIMALS; ANOXIA; CARBON DIOXIDE; FEMALE; FIBROSIS; KERATIN-14; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; NECROSIS; NITROIMIDAZOLES; OXYGEN; RADIATION-SENSITIZING AGENTS; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 75349096634     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2541090395     Document Type: Article

References (35)

1. Harris AL. Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2(1):38-47.
2. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93(4):266-276.
3. Hohenberger P, Felgner C, Haensch W, Schlag PM. Tumor oxygenation correlates with molecular growth determinants in breast cancer. Breast Cancer Res Treat 1998;48(2):97-106.
4. 2 tension measurements. Cancer Res 1991;51(12):3316-3322.
5. Van den Eynden GG, Colpaert CG, Couvelard A, et al. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph) angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology 2007;51(4):440-451.
6. Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treat 2003;81(2):137-147.
7. Tatum JL, Kelloff GJ, Gillies RJ, et al. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006;82(10):699-757.
8. Padhani AR. Where are we with imaging oxygenation in human tumours? Cancer Imaging 2005;5:128-130.
9. Robinson SP. Blood oxygenation level dependent (BOLD) imaging of tumours. In: Padhani AR, Choyke PL, eds. New techniques in oncologic imaging. New York, NY: Taylor & Francis, 2006;257-272.
10. Robinson SP, Rijken PF, Howe FA, et al. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J Magn Reson Imaging 2003;17(4):445-454.
11. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR). Guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 1998;77(1):1-10.
12. Williams JC, Gusterson BA, Humphreys J, et al. N-methyl-N-nitrosourea- induced rat mammary tumors: hormone responsiveness but lack of spontaneous metastasis. J Natl Cancer Inst 1981;66(1):147-155.
13. Howe FA, Robinson SP, Rodrigues LM, Griffiths JR. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn Reson Imaging 1999;17(9):1307-1318.
14. Robinson SP, Rodrigues LM, Howe FA, Stubbs M, Griffiths JR. Effects of different levels of hypercapnic hyperoxia on tumor R2* and arterial blood gases. Magn Reson Imaging 2001;19(2):161-166.
15. Raleigh JA, Chou SC, Tables L, Suchindran S, Varia MA, Horsman MR. Relationship of hypoxia to metallothionein expression in murine tumors. Int J Radiat Oncol Biol Phys 1998;42(4):727-730.
16. Kostourou V, Troy H, Murray JF, et al. Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo. Neoplasia 2004;6(4):401-411.
17. Motulsky HJ, Brown RE. Detecting outliers when fitting data with nonlinear regression: a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics 2006;7:123.
18. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26(2):225-239.
19. Rodrigues LM, Stubbs M, Robinson SP, Newell B, Mansi J, Griffiths JR. The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods. MAGMA 2004;17(3-6):260-270.
20. Padhani AR, Ah-See MLW, Taylor NJ, et al. MRI correlates of tumour grade and hypoxia status in human breast cancer [abstr]. In: Proceedings of the Thirteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2005; 90.
21. Padhani AR, Ah-See MLW, Taylor NJ, et al. An investigation of histological and DC-MRI correlates of intrinsic susceptibility contrast relaxivity (R2*) in human breast cancer [abstr]. In: Proceedings of the Thirteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif:International Society for Magnetic Resonance in Medicine, 2005; 1846.
22. Mayer A, Höckel M, Vaupel P. Endogenous hypoxia markers:case not proven ! Adv Exp Med Biol 2008; 61:127-136.
23. Alonzi R, Padhani AR, Maxwell RJ, et al. Carbogen breathing increases prostate cancer oxygenation:a translational MRI study in murine xenografts and humans. Br J Cancer 2009;100(4):644-648.
24. Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J Cancer Res 1996;87(4):385-394.
25. Brown E, McKee T, diTomaso E, et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 2003;9(6):796-800.
26. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints:preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95.
27. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003;67(1):3-15.
28. Al-Hallaq HA, River JN, Zamora M, Oikawa H, Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 1998;41(1):151-159.
29. 2) inside tumors? Magn Reson Med 2002;48(6):980-986.
30. Robinson SP, Collingridge DR, Howe FA, Rodrigues LM, Chaplin DJ, Griffiths JR. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12(2):98-106.
31. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, et al. Changes in oxygenation of intracranial tumors with carbogen:a BOLD MRI and EPR oximetry study. J Magn Reson Imaging 2002;16(5):511-521.
32. Jiang L, McColl R, Weattherall P, Tripathy D, Mason RP. Blood oxygenation level dependent (BOLD) and Gd-DTPA contrast MRI for early evaluation of breast cancer chemotherapy [abstr]. In:Proceedings of the Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif:International Society for Magnetic Resonance in Medicine, 2006; 576.
33. Fischer DR, Reichenbach JR, Rauscher A, Sedlacik J, Kaiser WA. Application of an exogenous hyperoxic contrast agent in MR mammography:initial results. Eur Radiol 2005;15(4):829-832.
34. Hoskin PJ, Carnell DM, Taylor NJ, et al. Hypoxia in prostate cancer: Correlation of BOLD-MRI with pimonidazole immunohistochemistry: initial observations. Int J Radiat Oncol Biol Phys 2007;68(4):1065-1071.
35. Alonzi R, Padhani AR, Taylor NJ, et al. Sensitivity and specificity of functional MRI to map tumour hypoxia in the human prostate gland [abstr]. In:Proceedings of the Sixteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2008; 167.